165 related articles for article (PubMed ID: 22987617)
21. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma.
Chiang WF; Liu SY; Fang LY; Lin CN; Wu MH; Chen YC; Chen YL; Jin YT
Oral Oncol; 2008 Apr; 44(4):325-34. PubMed ID: 17588803
[TBL] [Abstract][Full Text] [Related]
23. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma.
Yamada S; Yanamoto S; Yoshida H; Yoshitomi I; Kawasaki G; Mizuno A; Nemoto TK
Int J Oral Maxillofac Surg; 2010 Jan; 39(1):61-7. PubMed ID: 19913389
[TBL] [Abstract][Full Text] [Related]
24. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis.
Villaret DB; Wang T; Dillon D; Xu J; Sivam D; Cheever MA; Reed SG
Laryngoscope; 2000 Mar; 110(3 Pt 1):374-81. PubMed ID: 10718422
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
27. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
28. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
29. Assessment of gene expression in head and neck carcinoma using laser capture microdissection and real-time reverse transcription polymerase chain reaction.
Malhotra PS; Malekfzali A; Bonner RF; Juhn S; Van Waes C; Chen Z
Laryngoscope; 2004 Dec; 114(12):2123-8. PubMed ID: 15564832
[TBL] [Abstract][Full Text] [Related]
30. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
31. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.
Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM
Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335
[TBL] [Abstract][Full Text] [Related]
32. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
33. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
34. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
35. Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.
Kao SY; Tsai MM; Wu CH; Chen JJ; Tseng SH; Lin SC; Chang KW
Head Neck; 2016 Apr; 38(4):522-8. PubMed ID: 25351569
[TBL] [Abstract][Full Text] [Related]
36. Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Weaver AN; Burch MB; Cooper TS; Della Manna DL; Wei S; Ojesina AI; Rosenthal EL; Yang ES
Mol Cancer Res; 2016 Sep; 14(9):883-91. PubMed ID: 27353029
[TBL] [Abstract][Full Text] [Related]
37. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
[TBL] [Abstract][Full Text] [Related]
38. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
